Clinical Trial: NCT04024254
A Study of Serum Folate Levels in Patients Treated With Olaparib
Status:
COMPLETEDPhase:
Phase 4| Lead Sponsor: | Rush University Medical Center |
| Information Provided By: | Rush University Medical Center |
| Last Update Posted: | 2026-03-04 |
Study Overview
Brief Summary
This is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.
Official Title
A Study of Serum Folate Levels in Patients With Treated With Olaparib.
Conditions
Ovarian Cancer, Breast Cancer, Folic Acid Deficiency
Intervention / Treatment
- Drug: Folic Acid Tablet
Other Study ID Numbers
- 18070604
Start Date (Actual)
2020-07-21
Primary Completion Date (Actual)
2025-12-31
Study Completion Date (Actual)
2025-12-31
Enrollment (Actual)
10
Study Type
Interventional
Phase
Phase 4
| Lead Sponsor: | Rush University Medical Center |
| Information Provided By: | Rush University Medical Center |
| Last Update Posted: | 2026-03-04 |
Study Overview
Brief Summary
This is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.
Official Title
A Study of Serum Folate Levels in Patients With Treated With Olaparib.
Conditions
Ovarian Cancer, Breast Cancer, Folic Acid Deficiency
Intervention / Treatment
- Drug: Folic Acid Tablet
Other Study ID Numbers
- 18070604
Start Date (Actual)
2020-07-21
Primary Completion Date (Actual)
2025-12-31
Study Completion Date (Actual)
2025-12-31
Enrollment (Actual)
10
Study Type
Interventional
Phase
Phase 4